A specialized diagnostic test for molecular classification of medulloblastoma tumors. This test identifies molecular subtypes to guide treatment selection and prognosis assessment.
Manufactured by
China
HaploX Biotechnology specializes in tumor liquid biopsy and genetic big data technologies. The company operates CAP/CLIA/EMQN/NCCL certified medical laboratories equipped with advanced gene sequencing platforms. Services cover tumor management, hereditary disease screening, and infectious disease detection, serving hundreds of hospitals and research institutions across China with international operations in Hong Kong, Singapore, Japan, Europe, and North America.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
TRUPCR Europe Ltd
United Kingdom · 2 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 9 relevant products
PreceDo Pharmaceuticals Co.Ltd.
China · 1 relevant product
Beijing SynsorBio Technology Co., Ltd
China · 1 relevant product
Hangzhou Biotest Biotech Co., Ltd
China · 1 relevant product
Biopsense Oy
Finland · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 5 relevant products
GeneCker Co., Ltd.
South Korea · 2 relevant products
Burning Rock Dx Co. Ltd.
China · 5 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 1 relevant product
53 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 100 closest product alternatives
TRUPCR Europe Ltd · United Kingdom
A molecular diagnostic kit for detecting and differentiating IDH1 and IDH2 mutations. Designed for comprehensive identification and characterization of IDH mutations in oncology and haematology applications.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic solution based on DNA methylation technology for identification and characterization of genetic diseases. Enables comprehensive genetic disease screening and diagnosis.
PreceDo Pharmaceuticals Co.Ltd. · China
A high-throughput drug sensitivity testing platform utilizing renewable primary cancer cells to predict treatment response. This service enables personalized treatment selection through comprehensive chemotherapy and targeted drug profiling.
Beijing SynsorBio Technology Co., Ltd · China
CRISPR-based molecular diagnostic test for tumor detection utilizing proprietary isothermal amplification and microfluidic integration. Enables rapid point-of-care testing with high sensitivity and specificity for oncology screening and monitoring applications.
Hangzhou Biotest Biotech Co., Ltd · China
A diagnostic test for detecting tumor markers in patient samples. This test is used in oncology screening and monitoring.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A specialized DNA methylation-based test for early detection and diagnosis of colorectal cancer. The test provides risk stratification and early screening capabilities for colorectal malignancies.
Biopsense Oy · Finland
Blood test panel for detecting and characterizing genetic and epigenetic mutations in circulating tumor DNA. Helps determine cancer origin, measure tumor burden, and identify new mutations during targeted therapy treatment.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic test utilizing DNA methylation technology for early detection of lung cancer. Enables risk assessment and early diagnosis of lung malignancies through liquid biopsy methodology.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
In vitro diagnostic test for identifying and quantifying cancer-related biomarkers. Supports oncology diagnosis, prognosis, and treatment monitoring.
GeneCker Co., Ltd. · South Korea
Molecular diagnostic test using CRISPR/Cas9 technology to identify and amplify mutant DNA sequences in patient samples. Provides standardized detection and quantification of cancer-related genetic mutations.
Burning Rock Dx Co. Ltd. · China
Multiplex immunoassay platform for detecting circulating cancer biomarkers in blood samples. Facilitates early diagnosis and treatment response monitoring in oncology patients.
BioChain (Beijing) Science & Technology. Inc. · China
A comprehensive blood-based screening service designed to detect multiple cancer types simultaneously through gene methylation analysis. This service utilizes advanced NGS technology and is available as a clinical testing service.
88 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products